 |
|
Sedative Use in the Last Week of Life and the Implications for End-of-Life Decision Making
Nigel Sykes, MA, BM, BCh, FRCGP;
Andrew Thorns, MBBS, MA, MRCGP
Arch Intern Med. 2003;163:341-344.
Background The use of sedation at the end of life has aroused ethical controversy, attracting accusations of hastening death by gradually increasing sedative doses. The doctrine of double effect has been introduced as an ethical defense. This study aimed to determine how sedative doses change at the end of life and how often the doctrine of double effect might be relevant.
Methods Case note review was performed of 237 consecutive patients who died in a specialist palliative care unit. Sedative dose changes during the last week of life were noted and survival from admission was compared between groups of patients receiving no sedation, sedation for 7 days, or a commencement of sedation in the last 48 hours of life. There was detailed review of notes from patients who received a marked increase in sedative dose to explore the applicability of the doctrine of double effect.
Results Sedation was given to 48% of patients. Of these, 13% received sedatives for 7 days or more, while 56% commenced sedative use only in the last 48 hours of life. The groups receiving no sedation or sedation for less than 48 hours had the shortest survival from admission (mean, 14.3 and 14.2 days), whereas the 7-day sedation group survived for a mean of 36.6 days (P<.001). Sedative use and dose increased toward the end of life, but the detailed case note review disclosed only 2 cases where the doctrine of double effect may have been implicated.
Conclusion Sedative dose increases in the last hours of life were not associated with shortened survival overall, suggesting that the doctrine of double effect rarely has to be invoked to excuse sedative prescribing in end-stage care.
From St Christopher's Hospice, London, England. Dr Thorns is now with Pilgrims Hospices and East Kent Hospitals National Health Service Trust, Margate, England.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study
Reuzel et al.
Palliat Med 2008;22:641-646.
ABSTRACT
Dealing With Delicate Issues in Continuous Deep Sedation: Varying Practices Among Dutch Medical Specialists, General Practitioners, and Nursing Home Physicians
Hasselaar et al.
Arch Intern Med 2008;168:537-543.
ABSTRACT
| FULL TEXT
Terminal sedation and the "imminence condition"
Cellarius
J. Med. Ethics 2008;34:69-72.
ABSTRACT
| FULL TEXT
Having a difficult time leaving: experiences and attitudes of nurses with palliative sedation
Rietjens et al.
Palliat Med 2007;21:643-649.
ABSTRACT
Improving Prescription in Palliative Sedation: Compliance With Dutch Guidelines
Hasselaar et al.
Arch Intern Med 2007;167:1166-1171.
ABSTRACT
| FULL TEXT
Lethal opioids or dangerous prescribers?
George and Regnard
Palliat Med 2007;21:77-80.
The Ethics of Palliative Sedation as a Therapy of Last Resort
National Ethics Committee, Veterans Health Adminis
AM J HOSP PALLIAT CARE 2007;23:483-491.
ABSTRACT
Palliative Sedation in Dying Patients: "We Turn to It When Everything Else Hasn't Worked"
Lo and Rubenfeld
JAMA 2005;294:1810-1816.
ABSTRACT
| FULL TEXT
Legalised euthanasia will violate the rights of vulnerable patients
George et al.
BMJ 2005;331:684-685.
FULL TEXT
Medical house officers' attitudes toward vigorous analgesia, terminal sedation, and physician-assisted suicide
Kaldjian et al.
AM J HOSP PALLIAT CARE 2004;21:381-387.
ABSTRACT
Emotional burden of nurses in palliative sedation therapy
Morita et al.
Palliat Med 2004;18:550-557.
ABSTRACT
Physician Reports of Terminal Sedation without Hydration or Nutrition for Patients Nearing Death in the Netherlands
Rietjens et al.
ANN INTERN MED 2004;141:178-185.
ABSTRACT
| FULL TEXT
End-of-Life Practices in European Intensive Care Units
Kompanje
JAMA 2003;290:2938-2939.
FULL TEXT
|
